Tempus AI vs Triomics (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: Tempus AI does not list a price
Free plan
Tie
Neither has one
Higher rating
Tempus AI
4.3 against 4.0
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	Tempus AI	Triomics
Our rating	4.3Better	4.0
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	Machine learning applied to genomic and clinical data for precision treatment matching One of the largest connected libraries of clinical and molecular data Publicly traded on Nasdaq under the ticker TEM Q1 2026 revenue of $348.1M, up 36.1% year over year 2026 revenue guidance raised to $1.59-$1.60 billion	AI built specifically for oncology rather than general medicine Clinical trial matching against unstructured patient records Structuring of oncology data for downstream decision support Support across the cancer care decision pathway Designed to assist rather than replace clinician judgement
Pros	Publicly reported financials give unusual transparency into scale and growth Massive, growing data library strengthens precision-matching over time Strong, consistent revenue growth across both diagnostics and data segments	Trial matching addresses a real and higher-priced manual bottleneck Oncology specialisation rather than a general clinical tool Helps surface treatment options patients would otherwise miss
Cons	Pricing runs through insurance billing and enterprise agreements, not published rates Built specifically for precision medicine and oncology, a narrower clinical scope Best suited to institutions already positioned to act on genomic testing results	Clinical deployment requires validation and governance review No published pricing; enterprise health system sales
Company	Tempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260729. Check the vendor before you buy.

FAQ

Questions people ask

Is Tempus AI better than Triomics?

In our reviews Tempus AI scores 4.3 and Triomics scores 4.0. The better pick depends on the job. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue. Triomics: AI for oncology workflows, supporting clinical trial matching and cancer care decisions.

Which is cheaper, Tempus AI or Triomics?

Tempus AI: see pricing. Triomics: see pricing.

Do Tempus AI and Triomics have free plans?

Neither lists a free plan.

More comparisons

Tempus AI compared with

All Tempus AI alternatives

Triomics compared with

All Triomics alternatives